Risk factors
Pacira BioSciences (PCRX) risk factors
Item 1A of every Pacira BioSciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors99 risks12 new9 dropped58 reworded
Pacira faces key risks in commercializing EXPAREL and ZILRETTA against generic and competitive pressures, managing manufacturing and supply chain vulnerabilities, and navigating stringent regulatory environments.
Filed Feb 26, 2026 - FY2024 10-K risk factors96 risks
Commercial success depends heavily on flagship products EXPAREL and ZILRETTA. Operations rely on complex third-party manufacturing, global supply chains, and strict regulatory compliance.
Filed Feb 27, 2025